Skip to main content
. 2018 Mar 12;51(1):119–127. doi: 10.4143/crt.2018.019

Fig. 2.

Fig. 2.

Kaplan-Meier curve of progression-free survival. IP, irinotecan/cisplatin; EP, etoposide/cisplatin; HR, hazard ratio; CI, confidence interval.